Jakavi 5mg Tablet
Jakavi 5mg Tablet
Ruxolitinib (5mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Jakavi 5mg Tablets: For Patients with Intermediate to Severe Myelofibrosis
Ruxolitinib 5mg tablets are prescribed for the treatment of intermediate to severe myelofibrosis, a rare blood cancer causing abnormal bone marrow growth and potential anemia. It's crucial to consult your doctor before starting or changing any medication.
Jakavi is an oral medication that targets specific molecules involved in the disease process, aiming to reduce red blood cell and platelet production while minimizing side effects. It works by disrupting the signal pathways within cells that contribute to myelofibrosis growth.
Key Benefits:
* Targeted therapy for Myelofibrosis: Specific to the disease's molecular mechanisms.
* Proven effectiveness: Helps control symptoms and slow disease progression.
* Oral administration: Convenient, easy-to-use dosing regimen.
Important Note: Jakavi is a prescription medication and must be prescribed and managed by your doctor. This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare professional regarding any questions or concerns about your health or treatment.
Active composition
Ruxolitinib 5 mg
About Ruxolitinib
Ruxolitinib is a kinase inhibitor used to treat myelofibrosis and polycythemia vera. It works by blocking signals that promote cancer cell proliferation. Ruxolitinib is effective in managing hematological malignancies. In summary, Ruxolitinib is beneficial for treating specific blood cancers.
How It Works
Ruxolitinib inhibits Janus kinases (JAK1 and JAK2), reducing signaling pathways that promote cell growth and survival in myeloproliferative disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jakavi 5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jakavi 5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jakavi 5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 5mg Tablet may be needed. Please consult your doctor. Use of Jakavi 5mg Tablet is not advised in patients with moderate to severe kidney disease.
Exercise Caution
Breastfeeding
Jakavi 5mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jakavi 5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 5mg Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jakavi 5mg Tablet